logo
Plus   Neg
Share
Email

Labcorp Adds Antigen Test To Screen For Active COVID-19 Infection

Laboratory Corporation of America Holdings (LH) announced the availability of a new laboratory-based antigen test that will help doctors determine if an individual is actively infected with COVID-19.

Developed by DiaSorin, the antigen test is available to patients through a doctor's order and allows for testing to determine if individuals are still infected with and could spread COVID-19.

The test is performed by a doctor or other healthcare provider using a nasal or nasopharyngeal swab to collect a sample and is then picked up and processed by Labcorp. Results are available on average within 24-48 hours from time of pick up.

The antigen test is the latest offering by Labcorp to fight COVID-19 at every stage, from diagnostic testing to clinical trials and vaccination services.

The DiaSorin LIAISON SARS-CoV-2 Ag antigen test has been made available to the U.S. market following notification to the U.S. Food and Drug Administration on October 26, 2020.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Intel Corp's Mobileye and self-driving delivery startup Udelv have signed a deal to launch a fully driverless delivery service in the United States by 2023. The companies plan to produce more than 35,000 Mobileye-driven Transporters by 2028. Domino's Pizza and autonomous vehicle startup Nuro are launching autonomous pizza delivery in Houston, this week. Some Domino's customers in Houston can have a pizza delivered by Nuro's R2 robot. CVS Health is now offering cost COVID-19 vaccines at select CVS Pharmacy locations in four more U.S. states as part of its ongoing effort to expand access to COVID-19 vaccines. It has now expanded the program to 51 more select locations in Arkansas, Nebraska, Iowa and Maine. It began in Washington, West Virginia, Delaware and New Mexico at 15 select locations from March 31.
Follow RTT